As of 2026-09-13, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -21.46 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 76.99 USD, the upside of Forte Biosciences Inc is -127.87%.
Based on its market price of 76.99 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 127.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -21.46 - -21.46 | -21.46 | -127.87% |
| P/E | (81.11) - (100.00) | (87.12) | -213.2% |
| DDM - Stable | (30.99) - (116.80) | (73.90) | -196.0% |
| DDM - Multi | (21.76) - (66.44) | (33.10) | -143.0% |
| Market Cap (mil) | 1,577.53 |
| Beta | 0.41 |
| Outstanding shares (mil) | 20.49 |
| Enterprise Value (mil) | 1,527.90 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.50% |
| Cost of Debt | 5.00% |
| WACC | 7.09% |